{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:53:53Z","timestamp":1781578433848,"version":"3.54.5"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T00:00:00Z","timestamp":1520899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0194208","type":"journal-article","created":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T13:31:03Z","timestamp":1520947863000},"page":"e0194208","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Clinical usefulness of the SAMe-TT2R2 score: A systematic review and simulation meta-analysis"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5177-1660","authenticated-orcid":true,"given":"Jasper H. A.","family":"van Miert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nic J. G. M.","family":"Veeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,3,13]]},"reference":[{"issue":"38","key":"ref1","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"P Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jamacardio.2016.0199","article-title":"Outcomes in a Warfarin-Treated Population With Atrial Fibrillation","volume":"1","author":"F Bj\u00f6rck","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1160\/TH16-06-0489","article-title":"Bleeding complications and mortality in warfarin-treated VTE patients, dependence of INR variability and iTTR","volume":"117","author":"P Sand\u00e9n","year":"2016","journal-title":"Thromb Haemost"},{"issue":"7","key":"ref4","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1111\/j.1538-7836.2006.01997.x","article-title":"Early detection of patients with a poor response to vitamin K antagonists: the clinical impact of individual time within target range in patients with heart disease","volume":"4","author":"NJGM Veeger","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"10","key":"ref5","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1111\/j.1538-7836.2010.03996.x","article-title":"Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA)","volume":"8","author":"AJ ROSE","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.thromres.2015.06.007","article-title":"Determinants of oral anticoagulation control in new warfarin patients: Analysis using data from Clinical Practice Research Datalink","volume":"136","author":"AF MacEdo","year":"2015","journal-title":"Thromb Res"},{"key":"ref7","first-page":"299","article-title":"HAS-BLED Predicts Warfarin Control in Australian Patients treated for Deep Vein Thrombosis","author":"K Mueller","year":"2016","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1378\/chest.13-0054","article-title":"Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT2R2 score","volume":"144","author":"S Apostolakis","year":"2013","journal-title":"Chest"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1378\/chest.13-2775","article-title":"Response","volume":"145","author":"S Apostolakis","year":"2014","journal-title":"Chest"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1378\/chest.13-2641","article-title":"Response","volume":"145","author":"S Apostolakis","year":"2014","journal-title":"Chest"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1160\/TH13-06-0443","article-title":"Vitamin K antagonists in heart disease: Current status and perspectives (Section III): Position paper of the ESC working group on thrombosis\u2014Task force on anticoagulants in heart disease","volume":"110","author":"R De Caterina","year":"2013","journal-title":"Thromb Haemost"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/europace\/euv088","article-title":"The SAMe-TT2R2 score and quality of anticoagulation in atrial fibrillation: a simple aid to decision-making on who is suitable (or not) for vitamin K antagonists","volume":"17","author":"L Fauchier","year":"2015","journal-title":"Europace"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0038-1651587","article-title":"A method to determine the optimal intensity of oral anticoagulant therapy","volume":"69","author":"FR Rosendaal","year":"1993","journal-title":"Thromb Haemost"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement","volume":"151","author":"D Moher","year":"2009","journal-title":"Ann Intern Med"},{"issue":"8","key":"ref15","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"PF Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"ref16","unstructured":"Hamm RM. Clinical Decision Making Spreadsheet Calculator;. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.med.emory.edu\/EMAC\/curriculum\/diagnosis\/oklahomaLRs.xls\" xlink:type=\"simple\">https:\/\/www.med.emory.edu\/EMAC\/curriculum\/diagnosis\/oklahomaLRs.xls<\/ext-link>."},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5","article-title":"What do we mean by validating a prognostic model?","volume":"19","author":"DG Altman","year":"2000","journal-title":"Stat Med"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting Meta-Analyses in R with the metafor Package","volume":"36","author":"W Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/europace\/euu353","article-title":"Evaluation of SAMe-TT2R2 risk score for predicting the quality of anticoagulation control in a real-world cohort of patients with non-valvular atrial fibrillation on vitamin-K antagonists","volume":"17","author":"RRY Abumuaileq","year":"2015","journal-title":"Europace"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.08.030","article-title":"The Sex, Age, Medical History, Treatment, Tobacco Use, Race Risk (SAMe TT2R2) Score Predicts Warfarin Control in a Singaporean Population","volume":"26","author":"N Bernaitis","year":"2017","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"e0150674","DOI":"10.1371\/journal.pone.0150674","article-title":"Use of the SAMe-TT2R2 Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke Incidence","volume":"11","author":"PH Chan","year":"2016","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.thromres.2016.09.021","article-title":"Evaluation of the SAMe-TT2R2 score to predict the quality of anticoagulation control in a cohort of patients with venous thromboembolism treated with vitamin K antagonists","volume":"147","author":"P Demelo-Rodr\u00edguez","year":"2016","journal-title":"Thromb Res"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.amjmed.2014.05.023","article-title":"SAMe-TT2R2 Score, Time in Therapeutic Range, and Outcomes in Anticoagulated Patients with Atrial Fibrillation","volume":"127","author":"P Gallego","year":"2014","journal-title":"Am J Med"},{"issue":"7\u20138","key":"ref24","first-page":"494","article-title":"Assessment of the mean time in the therapeutic INR range and the SAME-TT2R2 score in patients with atrial fibrillation and cognitive impairment","volume":"126","author":"P Gorzelak-Pabi\u015b","year":"2016","journal-title":"Polish Arch Intern Med"},{"issue":"11","key":"ref25","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.amjcard.2016.08.047","article-title":"Determinants of Time in Therapeutic Range in Patients Receiving Oral Anticoagulants (A Substudy of IMPACT)","volume":"118","author":"GYH Lip","year":"2016","journal-title":"Am J Cardiol"},{"issue":"7","key":"ref26","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1185\/03007995.2016.1164676","article-title":"Evaluation of SAMe-TT2R2 score and other clinical factors influencing the quality of anticoagulation therapy in non-valvular atrial fibrillation: a nationwide study in Spain","volume":"32","author":"JM Lobos-Bejarano","year":"2016","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1160\/TH15-10-0830","article-title":"The SAME-TT2R2 score predicts the quality of anticoagulation control in patients with acute VTE","volume":"115","author":"G Palareti","year":"2016","journal-title":"Thromb Haemost"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"192","DOI":"10.5853\/jos.2015.17.2.192","article-title":"Lack of Association of Clinical Factors (SAMe-TT2R2) with CYP2C9\/VKORC1 Genotype and Anticoagulation Control Quality","volume":"17","author":"YK Park","year":"2015","journal-title":"J Stroke"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s11739-014-1065-8","article-title":"A prospective validation of the SAME-TT2R2 score: how to identify atrial fibrillation patients who will have good anticoagulation control on warfarin","volume":"9","author":"D Poli","year":"2014","journal-title":"Intern Emerg Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ijcard.2016.04.131","article-title":"Relation of the SAMe-TT2R2 score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: Observations from the SPORTIF trials","volume":"216","author":"M Proietti","year":"2016","journal-title":"Int J Cardiol"},{"issue":"11","key":"ref31","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.amjmed.2015.05.036","article-title":"The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective \u2018Real-world\u2019 Inception Cohort Study","volume":"128","author":"V Rold\u00e1n","year":"2015","journal-title":"Am J Med"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1160\/TH15-02-0169","article-title":"Validation of the SAMe-TT2R2 score in a nationwide population of nonvalvular atrial fibrillation patients on vitamin K antagonists","volume":"114","author":"M Ruiz-Ortiz","year":"2015","journal-title":"Thromb Haemost"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ijcard.2015.11.158","article-title":"Usefulness of the SAME-TT2R2 score to predict anticoagulation control on VKA in patients with atrial fibrillation and obstructive sleep apnea","volume":"204","author":"FM Szymanski","year":"2016","journal-title":"Int J Cardiol"},{"issue":"12","key":"ref34","first-page":"1","article-title":"Pharmacogenetics-based versus conventional dosing of warfarin: A meta-analysis of randomized controlled trials","volume":"10","author":"C Shi","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"ref35","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1097\/MBC.0000000000000312","article-title":"Is the time in therapeutic range using the ratio of tests equivalent to the Rosendaal method?","volume":"26","author":"D Caldeira","year":"2015","journal-title":"Blood Coagul Fibrinolysis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0194208","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T16:02:24Z","timestamp":1570896144000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0194208"}},"subtitle":[],"editor":[{"given":"Michael","family":"Nagler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,3,13]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0194208","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,13]]}}}